Aleafia Health Announces Extension of Forbearance Under Loan Agreement With Senior Lender
June 01 2023 - 8:44AM
Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“
Aleafia
Health” or the “
Company”) announces that
the Company has entered into a forbearance agreement with NE SPC II
LP (“NE SPC”) extending the forbearance period under its loan
agreement with NE SPC until June 5, 2023. The forbearance agreement
comes in light of ongoing negotiations between the Company, NE SPC
and a potential alternative lender regarding a potential
refinancing of the indebtedness existing under the Company’s loan
agreement with NE SPC dated December 24, 2021 and as previously
amended by agreements dated March 28, 2022, June 17, 2022, and May
15, 2023 (the “
Loan Agreement”).
As previously disclosed by the Company, NE SPC
recently agreed to amend the terms of the Loan Agreement and to
forbear from enforcing its rights under the Loan Agreement until
the earlier of (a) an event of default, or (b) May 31, 2023.
No decisions relating to any potential
refinancing have been made as at the date of this news release and
the Company does not intend to comment further with respect to a
potential refinancing, or any other transaction which may result
from the strategic review process announced by the Company on May
25, 2023, unless and until it determines that additional disclosure
is appropriate in the circumstances and in accordance with
applicable securities laws.
For Investor & Media
Relations
Matthew Sale, CFOIR@Aleafiahealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
The Company is a federally licensed Canadian
cannabis company offering cannabis products in Canadian adult-use
and medical markets and in select international markets, including
Australia and Germany. The Company operates a virtual medical
cannabis clinic staffed by physicians and nurse practitioners which
provide health and wellness services across Canada.
The Company owns three licensed cannabis
production facilities and operates a strategically located
distribution centre all in the province of Ontario, including the
largest, outdoor cannabis cultivation facility in Canada. The
Company produces a diverse portfolio of cannabis and cannabis
derivative products including dried flower, pre-roll, milled,
vapes, oils, capsules, edibles, sublingual strips and topicals.
Cautionary Note Regarding
Forward-Looking Statements
Certain statements herein relating to the
Company constitute “forward-looking information” within the meaning
of applicable securities laws. Any statement that involves
discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, assumptions, future events or
performance (often but not always using phrases such as “expects”,
or “does not expect”, “is expected”, “anticipates” or “does not
anticipate”, “plans”, “budget”, “scheduled”, “forecasts”,
“estimates”, “believes” or “intends” or variations of such words
and phrases or stating that certain actions, events or results
“may” or “could”, “would”, “might” or “will” be taken to occur or
be achieved) are not statements of historical fact and may be
forward-looking statements. In this news release, forward-looking
statements relate to, among other things, statements regarding: the
ability of the Company, NE SPC and the potential alternative lender
to successfully negotiate a potential refinancing, the potential
results and timing of the Company’s strategic review process, and
the potential structure and timing of one or more potential
transactions which may result from that process. Forward-looking
statements are necessarily based upon a number of estimates and
assumptions that, while considered reasonable, are subject to known
and unknown risks, uncertainties, and other factors which may cause
the actual results and future events to differ materially from
those expressed or implied by such forward-looking statements. Such
factors include, but are not limited to: general business,
economic, competitive, political and social uncertainties; the
inability of the Company to obtain adequate financing; the delay or
failure to receive regulatory approvals; and other factors
discussed in the Company’s filings, available on the SEDAR website
at www.sedar.com. There can be no assurance that such
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on
the forward-looking statements and information contained in this
news release. Except as required by law, the Company assumes no
obligation to update the forward-looking statements of beliefs,
opinions, projections, or other factors, should they change.
Aleafia Health (TSX:AH.DB)
Historical Stock Chart
From Oct 2024 to Nov 2024
Aleafia Health (TSX:AH.DB)
Historical Stock Chart
From Nov 2023 to Nov 2024